Axxam Awarded EcoVadis Silver Medal for Sustainability Performance
23 September 2026
Axxam Awarded EcoVadis Silver Medal for Sustainability Performance Read More »
News
Axxam validates cardiac organoid platform from Molecular Devices and HeartBeat.bio
Axxam validates cardiac organoid platform developed by Molecular Devices and HeartBeat.bio for drug discovery and early derisking
Axxam validates cardiac organoid platform from Molecular Devices and HeartBeat.bio Read More »
Axxam and BiomimX collaborate on Organ-on-Chip drug discovery
Axxam and BiomimX collaborate to advance human-relevant drug discovery with next-generation Organ-on-Chip technologies
Axxam and BiomimX collaborate on Organ-on-Chip drug discovery Read More »
Axxam and HeartBeat.bio advance cardiovascular drug discovery
Axxam and HeartBeat.bio partner to advance human-relevant cardiovascular drug discovery and cardiac safety assessment
Axxam and HeartBeat.bio advance cardiovascular drug discovery Read More »
Axxam and Tessara join forces for neuroscience drug discovery
Axxam and Tessara collaborate to advance next-generation neuroscience drug discovery using human-relevant 3D models
Axxam and Tessara join forces for neuroscience drug discovery Read More »
Axxam and B’SYS collaboration on ion channels
Axxam and B’SYS partner to expand access to validated ion channel cell lines for high-throughput electrophysiology
Molecular Health and Axxam drive discovery of new drug targets
Molecular Health and Axxam enter into a strategic partnershipto bolster the discovery of innovative targets in drug development
Molecular Health and Axxam drive discovery of new drug targets Read More »
Axxam and X-Chem join forces on DEL screening
Axxam and X-Chem announce a collaboration combining deep expertise in biology and high-performance DEL screening
